From improving brain health, performance, and resilience to advancing the care of brain disorders, the Rockefeller Neuroscience Institute is bringing the same level of success and rapid advances that have occurred in areas such as heart disease and cancer to brain and spine health.
The Institute is also developing partnerships and accelerating innovative technologies, treatments, and protocols.
Through a new vision and strategic thrust for neuroscience at WVU, and through basic, applied, and translational/clinical research, the Rockefeller Neuroscience Institute is a global leader in the discovery, development, and delivery of world-class research in human performance and brain health.
Over the next year, the Institute, along with its worldwide academic, government, and corporate partners, will unveil its groundbreaking programs and initiatives and will establish a continuum of functionality across diverse populations, including athletics, the military, and patients (AMP). The Institute’s leadership will also work closely with other WVU departments, such as engineering and computer science, to develop new medical technologies and collaborate with other medical specialties, such as cardiology.
Human Performance Research
As part of our research, we are looking at a variety of recovery modalities that can help speed recovery, such as photo bio-modulation, float tanks, and transcranial magnetic stimulation. We also examine people along a continuum of functionality and do so for athletes, military members, and patients. A special focus is placed on maximizing the performance of warriors of the Special Operations Component Commands of the Army, Marine Corps, Navy, and Air Force of the United States Armed Forces. Specific examples include Navy Seals and Army Special Forces (Green Berets).
Circadian Rhythm and Sleep
Brain-Computer Interface and Neurophysiology
Judi’s Journey with Alzheimer’s
Neurological surgeons, neurologists, and neuropsychologists at the West Virginia University Rockefeller Neuroscience Institute were the first in the world to use focused ultrasound to treat a patient with Alzheimer’s disease. Judi is the first patient to undergo the phase II clinical trial led by Dr. Ali Rezai, the Institute’s leader.